<DOC>
	<DOCNO>NCT02754414</DOCNO>
	<brief_summary>This platelet transfusion study . The purpose study measure life span quality platelet preserve additive solution store refrigerator . Participants give platelet apheresis . Platelets store 3 -20 day . A small portion subject 's stored platelet tag radioactive isotope infuse back participant . This enable u track many transfused platelet survive storage refrigerator .</brief_summary>
	<brief_title>Cold Apheresis Platelets Isoplate</brief_title>
	<detailed_description>A double hyperconcentrated apheresis platelet unit collect healthy adult volunteer subject use Trima Accel® Automated Blood Collection System . Concurrent plasma collect . After collection unit split two equal portion re-suspended 65 % Isoplate ( platelet additive solution ) 35 % plasma half suspend plasma . Both unit achieve final platelet concentration ~1500 x 103 platelets/μL . Both unit store , without agitation , 4°C . The plasma suspend unit ( control ) store 3 day , maximum platelet storage time allow refrigerated platelet FDA . The Isoplate/plasma unit ( test ) store 20 day . On Day 3 subject receive Indium 111 ( In-111 ) radiolabeled aliquot control plasma 4°C stored platelet . Follow-up sample subject collect approximately 2 hour post-infusion Days 1 ( 2X ) , 2 , 3 , 4 , 5 calculate recovery survival subject 's 3 day store platelet . On Day 1 sample draw 2 - 10 hour apart . The Isoplate 4°C store platelet initially store 10 day . The subject receive infusion In-111 aliquot 4°C Isoplate store platelet . Follow-up sample , , collect calculate platelet recovery survival test unit . These study allow comparison 3 10 day store platelet . Indium use label control test platelet available isotope , chromium , take refrigerated platelet . The In-111 administered Day 3 largely undetectable Day 10 therefore re-use isotope measure control test cold store platelet valid . Additionally , investigator collect pre-infusion radioactivity sample account residual In-111 , adjust calculation accordingly . Each subject 's Isoplate platelet recovery survival consider acceptable ≤20 % le subject 's correspond 3-day stored sample measurement . Acceptance criterion meet give storage time sample subject group meet acceptability threshold . So long acceptance criterion meet 5 split pair unit store 10 day investigator progressively increase storage period two day increment acceptance criterion longer met ( i.e. , least one subject &gt; 20 % reduction either recovery survival compare subject 's 3-day 4°C plasma store platelet ) . The investigator evaluate 12 , 14 , 16 , 18 20 day storage long test platelet 5 subject group demonstrate ≤20 % reduction recovery survival compare 3-day plasma 4°C stored platelet . Once first storage period fail meet acceptance criterion identify , investigator fall back one day evaluate mid storage period meet failed criterion . If mid-storage period fails , investigator evaluate prior storage period 5 additional sample , continue step back group meet acceptance criterion 10 subject . Thus , maximum acceptable storage time determine , total 10 subject satisfy acceptance criterion platelet viability data collect storage time . In addition radiolabeled platelet recovery survival measurement , various vitro assay perform end storage condition ( 3 day extend store ; i.e . 10 20 day ) .</detailed_description>
	<criteria>Weight : ≥ 125 pound Hematocrit : ≥ 38 % Platelet count : ≥ 225 X 10 3rd per microliter Temperature : ≤ 99.5 F Resting blood pressure : systolic ≤180 mmHg ; diastolic ≤ 100 mmHg Resting heart rate : 40 100 beat per minute Subjects must : least 18 year old , either sex Subjects must able read , understand sign inform consent document commit study followup schedule . The ability read speak English require participation . Subjects must good vein apheresis platelet collection draw blood sample . Subjects childbearing potential ( either male female ) must agree use effective method contraception course study . The following method contraception consider effective ; abstinence , intrauterine contraception device , hormonal method , barrier method history sterilization . Ever receive radiation therapy . Already participate 4 research study involve radioisotope within contemporaneous calendaryear . Taken aspirin , nonsteroidal antiinflammatory , platelet affect drug within 72 hour collection infusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Platelets</keyword>
	<keyword>transfusion</keyword>
	<keyword>cold storage</keyword>
	<keyword>apheresis</keyword>
	<keyword>Isoplate</keyword>
</DOC>